For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Newsletter
Fannie Mae, HIV Rates and Greenhouse Gases
Mortgage giant Fannie Mae announces a shakeup of its senior management. A new study finds New York City’s HIV infection rate to be three times…
Newsletter
West Nile, Union Corruption and Federal Courts
The West Nile Virus has infected individuals in 28 states so far this year. The Los Angeles Times publishes a 3-part series on corruption allegations…
Blog
Anna Tomalis, R.I.P.
Last Friday, I attended the funeral of a remarkable 13-year-old girl named Anna Tomalis. For the past three years, Anna had been battling terminal…
Op-Eds
Sick Patients Need Cutting-Edge Drugs
The story of Anna Tomalis trying to recieve a compassionate usage exemption from the FDA to treat her cancer.
Newsletter
Drug Approval at the FDA, Childhood Obesity and the War on Bottled Water
Industry analysts characterize the Food and Drug Administration’s drug approval process as especially “conservative.” An anti-obesity advertising campaign targeted at children generates controversy. Local government…
News Release
Reform Needed at the Food and Drug Administration
Washington, D.C., August 14, 2008—In order to best serve the interests of the nation’s patients and doctors, the structure of the…